BD Financial Statements
BD Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | September |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
BD Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 6,359.7 | 5,834.8 | 5,414.7 |
| Gross Profit ($ mil.) | 3,287.8 | 2,948.0 | 2,752.7 |
| Operating Income ($ mil.) | 1,203.2 | 1,050.5 | 1,031.2 |
| Total Net Income ($ mil.) | 890.0 | 752.3 | 722.3 |
| Diluted EPS (Net Income) | 3.49 | 2.93 | 2.77 |
BD Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,867.6 | 1,746.9 | 1,705.8 |
| Gross Profit ($ mil.) | 950.2 | 893.1 | 875.9 |
| Operating Income ($ mil.) | 409.6 | 381.6 | 362.7 |
| Total Net Income ($ mil.) | 297.1 | 276.2 | 271.5 |
| Diluted EPS (Net Income) | 1.18 | 1.09 | 1.07 |
BD Stock Quote & Chart
| 10/06/08 15:02:51 EST •
NYSE •
78.00
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
BD Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.05 | 2.19 | 1.56 |
| Price/Earnings Ratio | 19.29 | 22.29 | 15.82 |
| Price/Book Ratio | 4.18 | 2.28 | 1.52 |
| Price/Cash Flow Ratio | 13.42 | 15.76 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed BD Financial Ratios
BD Competitive Intelligence
| Abbott Labs | Baxter | Covidien | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 11,263.0 | 10,170.0 |
| Employees | 68,000 | 46,000 | 43,800 |
| Market Cap ($ mil.) | 90,488.8 | 43,566.0 | 26,889.8 |
Competitive Landscape





